VEGFB and cardiac hypertrophy: These findings indicated that the autocrine VEGF-B signaling in the developing heart leads to septal defects and in the surviving transgenic mice to cardiac hypertrophy with left ventricular dysfunction, thus providing a model of pathological cardiac hypertrophy.